MetaCap

ImageneBio Inc. Company Profile

NASDAQ: IMAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

3.920.00 (0.00%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ImageneBio at a glance

ImageneBio Inc. (NASDAQ: IMA) is a Biotechnology: Biological Products (No Diagnostic Substances) company in the Health Care sector headquartered in San Diego, CA. ImageneBio is led by Dr. Kristin Yarema Ph.D. and employs about 18 people. The company's shares have traded publicly since 2021.

At a market capitalization of $49.6 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001835579, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does ImageneBio do?

ImageneBio, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for patients with immunological, autoimmune and inflammatory diseases. Its lead product candidate includes IMG-007, a non-depleting anti-OX40 monoclonal antibody that binds to OX40 receptor on activated T cells to block receptor binding to OX40 ligand which is in Phase 1b/2a clinical trial. The company was formerly known as Ikena Oncology, Inc. and changed its name to ImageneBio, Inc. in July 2025. ImageneBio, Inc. is headquartered in San Diego, California.

Business description based on the company's public filings.

Company information

Legal name
ImageneBio Inc.
Ticker
NASDAQ: IMA
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
CEO
Dr. Kristin Yarema Ph.D.
Employees
18
Headquarters
12526 High Bluff Drive, San Diego, CA, United States
Phone
858 345 6265
IPO year
2021
Market cap
$49.58M
SEC CIK
0001835579
Latest annual report
10-K · Mar 10, 2026

Companies similar to ImageneBio

IMA peer companies
CompanyPrice% ChgMarket capCompare
AVXLAnavex Life Sciences Corp.0.5915-11.39%$54.83Mvs IMA
GRMLGreenland Mines Ltd.2.99+2.75%$44.31Mvs IMA
CGTXCognition Therapeutics Inc.0.5822-3.06%$55.37Mvs IMA
ELOXEloxx Pharmaceuticals Inc.10.69-1.75%$43.69Mvs IMA
OKYOOKYO Pharma Limited1.07-7.76%$56.15Mvs IMA
CHRSCoherus Oncology Inc.0.3698-4.47%$57.15Mvs IMA
INKTMiNK Therapeutics Inc.8.02-6.85%$41.17Mvs IMA
ELUTElutia Inc. Class A0.9001+11.12%$39.96Mvs IMA

Related